Valarie Higgins, Managing Director & President of Almac Clinical Technologies at Almac Group will be speaking at the British American Business Council of Greater Philadelphia‘s June 7th event:
–> The Future of Immune Health – A Fireside Chat Featuring Global Health Sciences Leaders Almac Group & Penn Medicine
Details: https://lnkd.in/eHXgNXVj
Imvax to sponsor & participate in Taking on Cancer: How the Philadelphia region is leading the fight against the deadly disease
The Greater Philadelphia has thousands of people — doctors, scientists, business executives and more — who go to work every day with a mission to make life better for those touched by cancer. The Philadelphia Business Journal has assembled nine of them to discuss the region’s cancer ecosystem.
News from a former Ambassador Award Honoree: Amicus Therapeutics Announces Issuance of New U.S. Composition of Matter Patent for Galafold® (migalastat), Strengthening Patent Protection Through 2038
Galafold U.S. Intellectual Property Protection Now Includes 35 Issued Patents, 18 of which expire in 2038
PHILADELPHIA, April 19, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,304,940, which is directed to a composition of matter covering migalastat (Galafold®).
The new U.S. patent titled “Methods of Treating Fabry Patients Having Renal Impairments” is directed to a molecule comprising migalastat bound to an alpha-galactosidase A protein and expires in 2038.
Acumen Analytics Launches ‘Life Sphere’ A New Podcast Dedicated to the People in Life Sciences.
The podcast features experts and advocates discussing trends, tools, careers and all components of the Life Sciences industry.
The first episodes of season one will be available May 3. New episodes will be released on Tuesdays. To learn more about Life Sphere, check the Acumen website for more details as they become available https://acumenanalytics.com/news/
Jefferson Health and Bayada to take ‘revolutionary step’ in home care with new joint venture
Philadelphia Business Journal
Jefferson Health and Bayada Home Health Care entered into a definitive agreement Tuesday to form a joint venture that will accelerate the transformation of post-acute care and digital health.
The joint venture, tentatively called “Jefferson Health at Home,” will serve Jefferson home care patients in New Jersey and Pennsylvania.